抗生素使用作为刺激性肠综合征的危险因素:来自全国范围的病例控制研究的结果
Kyle Staller1,2, Ola Olén3, Jonas Söderling3,4
1Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Alimentary pharmacology & therapeutics
|September 29, 2023
概括
以前使用抗生素显著增加了患上易怒肠综合征 (IBS) 的风险. 多次抗生素疗程显示,与IBS患病率增加的相关性最高.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 流行病学 流行病学
背景情况:
- 肠道微生物组在刺激性肠综合征 (IBS) 病理生理学中至关重要.
- 抗生素的使用对肠道微生物生态有深远的影响.
- 调查抗生素暴露与IBS之间的联系至关重要.
研究的目的:
- 检查先前使用抗生素与发展IBS的风险之间的关联.
- 量化与不同程度的抗生素暴露相关的IBS风险.
主要方法:
- 在瑞典 (2007年至2016年) 进行了一项基于人口的大规模病例控制研究.
- 包括29,111名IBS患者与135,172名对照进行匹配.
- 利用瑞典的健康登记册来追踪IBS诊断前一年的抗生素处置情况.
主要成果:
- 74.9%的IBS患者使用了抗生素,而对照组57.8%使用了抗生素.
- 以前使用抗生素与IBS的几率增加了两倍以上 (OR 2.21).
- 增加抗生素开放量 (1-2或≥3) 与更高的IBS几率相关 (OR分别为1.67和3.36).
结论:
- 抗生素的使用与IBS的风险增加有显著的关联.
- IBS的风险随着使用的抗生素疗程数量的增加而升级.
- 研究结果强调了抗生素对肠道健康和IBS发展的潜在长期影响.
相关概念视频
Irritable Bowel Syndrome I: Introduction
304
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
304
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
181
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
181
Drugs for Treatment of Diarrhea-Predominant IBS
200
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
200
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
143
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
143
Irritable Bowel Syndrome III: Medical and Nursing Management
225
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
225
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
348
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
348


